Elevance Health's CMS Sanction Deadline Extended: Key Insights and Analysis
The Centers for Medicare & Medicaid Services (CMS) has postponed potential sanctions against Elevance Health until July 1, following the company's progress in rectifying data submission deficiencies for its Medicare Advantage (MA) plans. Earlier, CMS had raised concerns that Elevance failed to submit necessary data related to its members' risk adjustment scores over a seven-year period, essential for determining accurate payments based on members' health statuses.
Initial warnings set compliance deadlines at the end of March, but Elevance, which denied any wrongdoing, requested additional time. Consequently, CMS extended the deadline to the end of May. Recent communications from CMS to Elevance's Medicare president, Aimee Dailey, indicate that the company has submitted corrected risk adjustment data and estimated overpayments through a wire transfer, with the exact amount undisclosed. Financial documents suggest Elevance's liability could range from $350 million to $1.5 billion.
Despite this progress, CMS’ MA enforcement director, John Scott, emphasized that Elevance must address any remaining errors in the CMS risk adjustment processing system by June’s end and return any additional overpayments identified by CMS. Failure to comply could lead to sanctions on July 1, potentially affecting new member enrollments and communication with current plan holders. Analysts suggest that such penalties might impact Elevance's reputation and broker relationships, influencing future membership growth.
An Elevance spokesperson stated the company is maintaining a constructive dialogue with regulators and remains hopeful about reaching a resolution. Analysts express optimism that Elevance is positioned to meet the remaining regulatory compliance requirements to avoid sanctions. TD Cowen analyst Ryan Langston noted in a recent analysis that the developments are a positive sign for Elevance's compliance efforts.
Moreover, CMS is expanding audits for MA plans and addressing review backlogs by investing in technology and enhancing its workforce in the medical coding division, showcasing a comprehensive approach to regulatory compliance and risk management.